Content about biopharmaceutical

February 12, 2014

Mallinckrodt and Cadence Pharmaceuticals on Tuesday announced that they have entered into a definitive agreement under which a subsidiary of Mallinckrodt will commence a tender offer to acquire all outstanding shares of Cadence Pharmaceuticals for $14.00 per share in cash.

February 12, 2014

America’s biopharmaceutical research companies currently are developing 180 new medicines to help the nearly 400 million people who have diabetes worldwide, the Pharmaceutical Research and Manufacturers of America announced Tuesday.

August 8, 2013

Keryx Biopharmaceuticals announced the submission of a new drug application to the Food and Drug Administration seeking approval for the marketing and sale of Zerenex (ferric citrate coordination complex), the company's drug candidate for the treatment of elevated serum phosphorus levels, or hyperphosphatemia, in patients with chronic kidney disease on dialysis.

April 26, 2013

More than 200 drugs for blood cancers are under development, according to a new report by a drug industry trade group.

March 11, 2013

Nearly 1,000 biotech drugs and vaccines for more than 100 diseases are currently under development, according to a new report.

October 5, 2012

Drug maker Takeda announced that its wholly owned U.S. subsidiary has entered a definitive agreement to acquire LigoCyte Pharmaceuticals, a private clinical-stage biopharmaceutical company focused on developing novel vaccines for gastrointestinal and respiratory indications.

September 17, 2012

CVS Caremark has appointed Thomas Moriarty as EVP and general counsel of CVS Caremark.

September 4, 2012

Rx Response, an initiative of America’s biopharmaceutical supply system to help ensure the continued flow of medicine to patients in a severe public health emergency, moved to its highest alert status last week as Hurricane Isaac made landfall in Louisiana and across the Gulf Coast.

July 30, 2012

In July, the country’s largest trade group representing the drug industry released a report showing nearly 200 drugs under clinical development or Food and Drug Administration review for treating mental disorders.


June 1, 2012

WebMD has tapped Pfizer's group president of animal health, consumer health care and corporate strategy to serve as its new chief executive.

May 9, 2012

The Food and Drug Administration should apply consistent regulatory standards across all biologics, Sandoz plans to state Friday in testimony at an FDA public hearing on draft guidances related to the development of biosimilars.

April 13, 2012

Drug companies invested nearly $50 billion in research and development in 2011, according to a new report by a drug industry trade group.

March 6, 2012

AmerisourceBergen on Tuesday announced that it has signed a definitive agreement to purchase World Courier Group, a privately held global specialty transportation and logistics provider for the biopharmaceutical industry, for $520 million in cash.

September 7, 2011

A specialty biopharmaceutical company has elected two members to its board of directors.

September 1, 2011

After entering a definitive agreement to acquire biopharmaceutical company Icagen, Pfizer has extended its tender offer for all outstanding shares of common stock.

August 30, 2011

The VP strategic alliances and partnerships for Pfizer's oncology division has joined the corporate advisory board at a development-stage oncology and dermatology biopharmaceutical company.

July 28, 2011

Pfizer has entered a definitive agreement to acquire a biopharmaceutical company that focuses on the development of pain treatments.

April 27, 2011

A biopharmaceutical company has appointed a new CFO.

March 30, 2011

A biopharmaceutical company that specializes in diabetes treatments has appointed a new board chairman.

March 9, 2011

Eli Lilly leader John Lechleiter has become something of an evangelist for medical innovation lately. On Wednesday, the Lilly chairman, president and CEO spoke to the U.S./Japan Business Council in Tokyo to call for changes and policies in the biopharmaceutical industry that encourage innovation, or “reinventing invention,” as he called it.

February 2, 2011

A new report developed by the Pharmaceutical Research and Manufacturers of America revealed that nearly 300 heart disease and stroke medicines are in development.

January 25, 2011

John Johnson is bidding Eli Lilly adieu.

December 21, 2010

Abbott has made a pact with a biopharmaceutical company to develop new cancer treatments by making small-molecule inhibitors.

December 21, 2010

A biopharmaceutical company exclusively will develop and commercialize oral formulations of a drug maker's insulins.

© 2014 Drug Store News. All Rights Reserved.